Drug intelligence / Profile preview

Ptac2S

Development stage
Preclinical
Modality
Small Molecules
Administration
Parenteral
01

Overview

Ptac2S (also known as [Pt(DMS)]) is a novel platinum(II) complex containing acetylacetonate (acac) and dimethylsulfoxide (DMS) ligands. Unlike cisplatin, which primarily targets genomic DNA, Ptac2S operates on non-genomic targets and has demonstrated the ability to circumvent cisplatin resistance in epithelial ovarian carcinoma (EOC) cell lines such as SKOV-3. It exhibits potent antitumor and antiangiogenic activities, significantly inhibiting tumor growth, cell proliferation, and microvessel density in preclinical models of renal cell carcinoma and ovarian cancer. Its mechanism of action involves the downregulation of pro-angiogenic factors, including vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMP1, MMP2, and MMP9), as well as significant alterations in cellular metabolism and lipid expression.

Other names
[Pt(O,O'-acac)(γ-acac)(DMS)]platinum(II) complex with acetylacetonate and dimethylsulfoxide
02

Targets

MMP1 (Matrix metalloproteinase-1)MMP2 (Matrix metalloproteinase-2)MMP9 (Matrix metalloproteinase-9)VEGFA (Vascular endothelial growth factor A)

Beyond the preview

Go deeper on Ptac2S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ptac2S.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call